CSCI

COSCIENS Biopharma Inc. Common Stock
CSCI

Overview Fund Activity

20 hedge funds and large institutions have $681K invested in COSCIENS Biopharma Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 5 closing their positions.

Holders
20
Holders Change
–
Holders Change %
0%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
6
Reduced
6
Closed
5
Calls
$54K
Puts
$63K
Net Calls
-$9K
Net Calls Change
-$19K

Top Buyers

1
JPMorgan Chase & Co
1
JPMorgan Chase & Co
New York
$120K
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$55K
3
PAG
3
Private Advisor Group
New Jersey
$42K
4
NCCM
4
Nine Chapters Capital Management
New Jersey
$38K
5
Simplex Trading
5
Simplex Trading
Illinois
$31K

Top Sellers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$67K
2
SM
2
Sabby Management
Florida
$0
3
KPF
3
K2 Principal Fund
Ontario, Canada
$0
4
FDCDDQ
4
Federation des caisses Desjardins du Quebec
Quebec, Canada
$72K
5
ARTA
5
A.R.T. Advisors
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Bank of America
26
Bank of America
North Carolina
$0 87 +77 +770%
1
2